Molecular Remission in Follicular Lymphoma: Is the Era of Residual Disease Monitoring Over? Reply

被引：0
|
作者：
van Oers, Marinus H. J. [1 ,2 ]
Jansen, Joop H. [3 ]
van der Reijden, Bert A. [1 ,3 ]
机构：
[1] Canc Lymphoma Grp, European Org Res & Treatment, Brussels, Belgium
[2] Univ Amsterdam, Acad Med Ctr, Dutch Belgian Cooperat Trial Grp Hematol Oncol, NL-1105 AZ Amsterdam, Netherlands
[3] Radboud Univ Nijmegen, Med Ctr, Nijmegen Ctr Mol Life Sci, NL-6525 ED Nijmegen, Netherlands
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2011年 / 29卷 / 11期
关键词：
D O I：
10.1200/JCO.2010.34.1495
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：E319 / E319
页数：1
相关论文
共 50 条
  • [1] Molecular Remission in Follicular Lymphoma: Is the Era of Residual Disease Monitoring Over?
    Prochazka, Vit
    Papajik, Tomas
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (11) : E318 - E318
  • [2] Prognostic Significance of Molecular Remission in Follicular Lymphoma Reply
    van Oers, Marinus H. J.
    Tonnissen, Evelyn
    van Glabbeke, Martine
    Giurgea, Livia
    Jansen, Joop H.
    Klasa, Richard
    Marcus, Robert E.
    Wolf, Max
    Kimby, Eva
    Vranovsky, Andrej
    Holte, Harald
    Hagenbeek, Anton
    van der Reijden, Bert A.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (30) : E614 - E614
  • [3] Is There a Role for Minimal Residual Disease Monitoring in Follicular Lymphoma in the Chemo-Immunotherapy Era?
    Gritti, Giuseppe
    Pavoni, Chiara
    Rambaldi, Alessandro
    [J]. MEDITERRANEAN JOURNAL OF HEMATOLOGY AND INFECTIOUS DISEASES, 2017, 9
  • [4] Minimal residual disease (MRD) in follicular lymphoma in the era of immunotherapy with rituximab
    Hirt, C
    Schüler, F
    Dölken, G
    [J]. SEMINARS IN CANCER BIOLOGY, 2003, 13 (03) : 223 - 231
  • [5] Quantitative molecular monitoring of circulating lymphoma cells for the detection of minimal residual disease in follicular and mantle cell lymphoma
    Schüler, F
    Hirt, C
    Dölken, L
    Krüger, W
    Dölken, G
    [J]. DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2005, 130 (38) : 2130 - 2134
  • [6] Prognostic Significance of Molecular Remission in Follicular Lymphoma
    Duehrsen, Ulrich
    Huettmann, Andreas
    Duerig, Jan
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (30) : E613 - E613
  • [7] Residual disease, a promising marker in follicular lymphoma
    Cazabat, Romain
    [J]. HEMATOLOGIE, 2024, 30 (02): : 105 - 106
  • [8] Molecular remission in follicular lymphoma - Theoretical concept or therapeutic goal?
    Rohatiner, A
    [J]. BRITISH JOURNAL OF CANCER, 2000, 83 : 7 - 7
  • [9] EFFICACY OF THE R-BENDAMUSTINE ON THE ERADICATION OF THE MOLECULAR MINIMAL RESIDUAL DISEASE IN FOLLICULAR LYMPHOMA
    Galimberti, S.
    Ercolano, G.
    Ciabatti, E.
    Grassi, S.
    Metelli, M. R.
    Guerrini, F.
    Iovino, L.
    Rigacci, L.
    Kovalchuk, S.
    Bosi, A.
    Vallisa, D.
    Falcinelli, F.
    Falzetti, F.
    Petrini, M.
    [J]. HAEMATOLOGICA, 2016, 101 : S45 - S45
  • [10] Monitoring of minimal residual disease after CHOP and rituximab in previously untreated patients with follicular lymphoma
    Rambaldi, A
    Lazzari, M
    Manzoni, C
    Carlotti, E
    Arcaini, L
    Baccarani, M
    Barbui, T
    Bernasconi, C
    Dastoli, G
    Fuga, G
    Gamba, E
    Gargantini, L
    Gattei, V
    Lauria, F
    Lazzarino, M
    Mandelli, F
    Morra, E
    Pulsoni, A
    Ribersani, M
    Rossi-Ferrini, PL
    Rupolo, M
    Tura, S
    Zagonel, V
    Zaja, F
    Zinzani, P
    Reato, G
    Foa, R
    [J]. BLOOD, 2002, 99 (03) : 856 - 862
12345